Kure Cells
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- $10M
Investors
- 4
About Kure Cells
Kure Cells Inc. is focused on developing advanced cell therapy solutions, particularly through its Ultra-Fast (UF) CAR-T platform. Founded in 2021, the company is headquartered in the United States.Kure Cells specializes in innovative cell therapy solutions, particularly through its proprietary Ultra-Fast (UF) CAR-T platform. This platform significantly enhances the manufacturing process of CAR-T therapies, reducing production time from several weeks to less than 24 hours while maintaining the critical attributes of T-cell stemness and therapeutic potency. The UF CAR-T platform focuses on treating hematological malignancies such as CD19-relapsed or refractory non-Hodgkin lymphoma and BCMA-relapsed or refractory multiple myeloma, exhibiting an impressive 88% complete remission rate in clinical trials.Kure Cells operates a business model that emphasizes partnerships and collaborations with clinical centers and strategic organizations to advance its cell therapy products. The company engages in B2B transactions, predominantly involving clinical trial operations and the commercialization of its CAR-T therapies. Revenue generation may involve arrangements for clinical trial support, manufacturing services, and agreements with healthcare providers to deliver its advanced therapies. Flagship products, such as the UF-kure19, are involved in structured pricing models that align with the therapeutic value delivered to healthcare institutions and patients. The company aims to introduce new products designed to further enhance treatment options for hematological malignancies. Furthermore, Kure Cells is focusing on expanding its market reach into new regions, including Asia and additional parts of Europe, by 2026.
Who invested in Kure Cells
4 investors across 1 round
See all investors in Kure Cells
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 12, 2025
Amount
$10M
Investors
Questions about Kure Cells
Who invested in Kure Cells?
Kure Cells has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kure Cells raised?
Kure Cells has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kure Cells last raise money?
Kure Cells's most recent round on record is a Series A, in Oct 2025.
What does Kure Cells do?
Kure Cells is a biotechnology company.
Where is Kure Cells headquartered?
Kure Cells is headquartered in US.
Which VCs invest in companies like Kure Cells?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kure Cells's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kure Cells? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.